Please assess the completion status of the following clinical trial:

Trial Title: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~The subject cannot be enrolled in the study before all of the following inclusion criteria (including test results) are met:~1. Subject is between 18-55 years of age.~2. Subject meets the following Diagnostic and Statistical Manual of Mental Disorders Fourth Edition - Text Revision (DSM-IV-TR) criteria for a diagnosis of BED:~3. Subject has a BED diagnosis.~4. Subject's BED is of at least moderate severity with subjects reporting at least 3 binge eating days per week.~5. Female subjects must have a negative serum B-HCG pregnancy test and a negative urine pregnancy test and agree to comply with any applicable contraceptive requirements.~Exclusion Criteria:~Subjects are excluded from the study if any of the following exclusion criteria are met:~1. Subject has concurrent symptoms of bulimia nervosa or anorexia nervosa.~2. Subject is receiving psychotherapy (eg, supportive psychotherapy, cognitive behavior therapy, interpersonal therapy) or weight loss support (eg, Weight Watchers) for BED.~3. Subject has used psychostimulants to facilitate fasting or dieting as a part of their BED.~4. Subject has a lifetime history of psychosis, mania, hypomania, dementia, or ADHD.~5. Subject is considered a suicide risk, has previously made a suicide attempt, or is currently demonstrating active suicidal ideation.~6. Subject has known history of symptomatic cardiovascular disease, advanced arteriosclerosis, structural cardiac abnormality, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems.~7. Subject has a history of moderate or severe hypertension.~8. Subject is female and pregnant or nursing.~9. Subject has had bariatric surgery, lap bands, duodenal stents, or other procedures for weight loss.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- SPD489 (Lisdexamfetamine dimesylate) (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).